A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs

Alper Daskapan,Lusiana Rusdi Idrus,Maarten J Postma,Bob Wilffert,Jos G. W. Kosterink,Ymkje Stienstra,Daniel J. Touw,Aase Bengaard Andersen,Adrie Bekker,Paolo Denti,Agibothu Kupparam Hemanth Kumar,Kidola Jeremiah,Awewura Kwara,Helen McIlleron,Graeme Meintjes,Joep J. van Oosterhout,Geetha Ramachandran,Neesha Rockwood,Robert J. Wilkinson,Tjip S. van der Werf,Jan-Willem C. Alffenaar

A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs

2018

Introduction Contrasting findings have been published regarding the effect of human immunodeficiency virus (HIV) on tuberculosis (TB) drug pharmacokinetics (PK).

Keywords:

Drug
Immunodeficiency
Virus
Pharmacology
Tuberculosis
Pharmacokinetics
Medicine
Ethambutol
Dosing
Pyrazinamide
Cmax
Systematic review
Rifampicin
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations